Sign In
Buy CSTL
$20.39
+0.680 (+3.45%)
At Close: Jun 03, 2026
Here's a roundup of top developments in the biotech space over the last 24 hours:
Scaling The Peaks
(Biotech stocks that hit 52-week highs March 9.)
Arcutis...
The Daily Biotech Pulse: Trevana Pain Drug Resubmission Accepted For Review, Can-Fite To Explore Treatment For COVID-19
01:05pm, Thursday, 05'th Mar 2020
Here's a roundup of top developments in the biotech space over the last 24 hours.Scaling The Peaks (Biotech Stocks Hitting 52-week highs on March 4) * 89bio Inc (NASDAQ: ETNB) * Arcus Biosciences In
Castle Biosciences Announces Issuance of First U.S. Patent Covering DecisionDx-Melanoma
12:00pm, Thursday, 05'th Mar 2020
Castle was issued its first U.S. patent related to DecisionDx-Melanoma.
Netflix And Dow Heavyweights Into The Earnings Confessional
01:23pm, Saturday, 18'th Jan 2020
Welcome to Seeking Alpha's Stocks to Watch - a preview of key events scheduled for the next week. Follow this account and turn the e-mail alert on to receive th
Houston-area biotech co. to hire, double office space after $73.6M IPO
07:34pm, Tuesday, 14'th Jan 2020
Friendswood-based Castle Biosciences Inc. (Nasdaq: CSTL) has growth in mind after closing a multimillion-dollar initial public offering in 2019. Derek Maetzold, founder, president and CEO of Castle B
Does Castle Biosciences (NASDAQ:CSTL) Have A Healthy Balance Sheet?
11:46am, Tuesday, 24'th Dec 2019
Legendary fund manager Li Lu (who Charlie Munger backed) once said, 'The biggest investment risk is not the volatility...
We reveal 4 reasons your sun cream might not be working, causing you to burn
04:22pm, Friday, 23'rd Jun 2017
IT’S summer in Britain and with the heatwave comes the inevitable rainbow of sunburn. With health bods ramming home the importance of sun cream there really is no excuse. Or is there? We all …
Skin Analytics Seeks Funds on Crowdcube to Battle Melanoma Using Smartphone App & Attachable Camera
04:33pm, Thursday, 15'th Oct 2015
Hoping to put an end to mortality rate for Melanoma, Skin Analytics has launched an equity crowdfunding campaign on Crowdcube to raise £450,000 for its new ear
Castle Biosciences Closes $11.7M Tranche of $20M Series F Financing
02:16pm, Monday, 27'th Jul 2015
Castle Biosciences, Inc., a provider of molecular diagnostics to improve cancer treatment decisions, today announced it has closed the first tranche of a $20 mi
